151 related articles for article (PubMed ID: 1385479)
1. Expression and localization of proteins of the complement system in human skin.
Dovezenski N; Billetta R; Gigli I
J Clin Invest; 1992 Nov; 90(5):2000-12. PubMed ID: 1385479
[TBL] [Abstract][Full Text] [Related]
2. Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysis.
Kuraya M; Yefenof E; Klein G; Klein E
Eur J Immunol; 1992 Jul; 22(7):1871-6. PubMed ID: 1378022
[TBL] [Abstract][Full Text] [Related]
3. Expression of complement receptor CR2 (CD21) on human subcorneal keratinocytes in normal and diseased skin.
Hunyadi J; Simon M; Kenderessy AS; Dobozy A
Dermatologica; 1991; 183(3):184-6. PubMed ID: 1835941
[TBL] [Abstract][Full Text] [Related]
4. Human complement regulatory proteins expressed on mouse A9 cells containing a human chromosome 1.
Seya T; Okada M; Hara T; Matsumoto M; Miyagawa S; Oshimura M
Immunology; 1991 Dec; 74(4):719-24. PubMed ID: 1723716
[TBL] [Abstract][Full Text] [Related]
5. Effects of UVB on the synthesis of complement proteins by keratinocytes.
Pasch MC; Okada N; Bos JD; Asghar SS
J Invest Dermatol; 1998 Oct; 111(4):683-8. PubMed ID: 9764854
[TBL] [Abstract][Full Text] [Related]
6. CR2 is the primary acceptor site for C3 during alternative pathway activation of complement on human peripheral B lymphocytes.
Marquart HV; Svehag SE; Leslie RG
J Immunol; 1994 Jul; 153(1):307-15. PubMed ID: 7515925
[TBL] [Abstract][Full Text] [Related]
7. An enzyme-linked immunosorbent assay for complement regulatory proteins and membrane-bound immunoglobulins on intact red blood cells.
Jones DR; Thompson RJ; Rao SA; Imrie H
J Immunol Methods; 1994 Dec; 177(1-2):235-42. PubMed ID: 7529808
[TBL] [Abstract][Full Text] [Related]
8. The influence of complement receptor type 1 (CD35) and decay-accelerating factor (CD55) on complement receptor type 2- (CD21) mediated alternative pathway activation by B cells.
Leslie RG
Immunology; 1999 Jul; 97(3):371-3. PubMed ID: 10447756
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation.
Seya T; Hara T; Matsumoto M; Akedo H
J Immunol; 1990 Jul; 145(1):238-45. PubMed ID: 1694203
[TBL] [Abstract][Full Text] [Related]
10. [Cell-associated complement regulatory proteins and their relation to disease processes].
Seya T
Rinsho Byori; 1991 Dec; 39(12):1317-24. PubMed ID: 1723433
[TBL] [Abstract][Full Text] [Related]
11. Hormonal regulation of complement components and receptors throughout the menstrual cycle.
Hasty LA; Lambris JD; Lessey BA; Pruksananonda K; Lyttle CR
Am J Obstet Gynecol; 1994 Jan; 170(1 Pt 1):168-75. PubMed ID: 7507644
[TBL] [Abstract][Full Text] [Related]
12. Protection of thyroid cancer cells by complement-regulatory factors.
Yamakawa M; Yamada K; Tsuge T; Ohrui H; Ogata T; Dobashi M; Imai Y
Cancer; 1994 Jun; 73(11):2808-17. PubMed ID: 7514955
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of complement C3 receptors on human astrocytes.
Gasque P; Chan P; Mauger C; Schouft MT; Singhrao S; Dierich MP; Morgan BP; Fontaine M
J Immunol; 1996 Mar; 156(6):2247-55. PubMed ID: 8690915
[TBL] [Abstract][Full Text] [Related]
14. CR1(CD35) and CR2(CD21) complement C3 receptors are expressed on normal human thymocytes and mediate infection of thymocytes with opsonized human immunodeficiency virus.
Delibrias CC; Mouhoub A; Fischer E; Kazatchkine MD
Eur J Immunol; 1994 Nov; 24(11):2784-8. PubMed ID: 7957570
[TBL] [Abstract][Full Text] [Related]
15. Decreased levels of complement receptor 1 (CD35) on B lymphocytes in persons with HIV infection.
Munson LG; Scott ME; Landay AL; Spear GT
Clin Immunol Immunopathol; 1995 Apr; 75(1):20-5. PubMed ID: 7533682
[TBL] [Abstract][Full Text] [Related]
16. Distribution of C3-step regulatory proteins of the complement system, CD35 (CR1), CD46 (MCP), and CD55 (DAF), in hematological malignancies.
Seya T; Matsumoto M; Hara T; Hatanaka M; Masaoka T; Akedo H
Leuk Lymphoma; 1994 Feb; 12(5-6):395-400. PubMed ID: 7514063
[TBL] [Abstract][Full Text] [Related]
17. Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).
Niehans GA; Cherwitz DL; Staley NA; Knapp DJ; Dalmasso AP
Am J Pathol; 1996 Jul; 149(1):129-42. PubMed ID: 8686736
[TBL] [Abstract][Full Text] [Related]
18. The epidermal growth factor receptor is a regulator of epidermal complement component expression and complement activation.
Abu-Humaidan AH; Ananthoju N; Mohanty T; Sonesson A; Alberius P; Schmidtchen A; Garred P; Sørensen OE
J Immunol; 2014 Apr; 192(7):3355-64. PubMed ID: 24591374
[TBL] [Abstract][Full Text] [Related]
19. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
[TBL] [Abstract][Full Text] [Related]
20. Detection of complement receptors 1 and 2 on mouse splenic B cells using flow cytometry.
Donius LR; Weis JH
Methods Mol Biol; 2014; 1100():305-10. PubMed ID: 24218269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
